We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

32 hedge funds and large institutions have $417K invested in Bionano Genomics in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

27% more capital invested

Capital invested by funds: $329K → $417K (+$88.3K)

10% more funds holding

Funds holding: 29 → 32 (+3)

0.48% less ownership

Funds ownership: 2.99% → 2.51% (-0.48%)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
32
Holders Change
+3
Holders Change %
+10.34%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
5
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$195K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$160K
3
CAM
Carret Asset Management
New York
+$79.5K
4
HF
HRT Financial
New York
+$64.6K
5
TSS
Two Sigma Securities
New York
+$49.5K

Top Sellers

Rank Fund Capital Flow
1
GCP
GSA Capital Partners
United Kingdom
-$131K
2
Morgan Stanley
Morgan Stanley
New York
-$17.3K
3
TRCT
Tower Research Capital (TRC)
New York
-$7.26K
4
SSG
Summit Securities Group
New York
-$3.93K
5
Group One Trading
Group One Trading
Illinois
-$531
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$109K +$195K +61,206 +2,292%
Vanguard Group
2
Vanguard Group
Pennsylvania
$86.3K +$160K +50,459 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$45.9K +$25.3K +7,967 +42%
CAM
4
Carret Asset Management
New York
$42.8K +$79.5K +25,000 New
HF
5
HRT Financial
New York
$34K +$64.6K +20,330 New
TSS
6
Two Sigma Securities
New York
$26.6K +$49.5K +15,584 New
Stifel Financial
7
Stifel Financial
Missouri
$18K +$33.4K +10,513 New
BlackRock
8
BlackRock
New York
$17K +$3 +1 +0%
Bank of America
9
Bank of America
North Carolina
$14.5K +$312 +98 +1%
Morgan Stanley
10
Morgan Stanley
New York
$10.6K -$17.3K -5,447 -47%
Osaic Holdings
11
Osaic Holdings
Arizona
$7.23K +$3.18K +1,000 +31%
Group One Trading
12
Group One Trading
Illinois
$2.32K -$531 -167 -11%
CWP
13
Concord Wealth Partners
Virginia
$1.71K +$3.18K +1,000 New
SS
14
SBI Securities
Japan
$400 -$149 -47 -17%
FFA
15
Farther Finance Advisors
California
$270 +$502 +158 New
Wells Fargo
16
Wells Fargo
California
$193 – – –
TRCT
17
Tower Research Capital (TRC)
New York
$43 -$7.26K -2,283 -99%
GWSG
18
GPS Wealth Strategies Group
Colorado
$27 – – –
BNP Paribas Financial Markets
19
BNP Paribas Financial Markets
France
$22 -$137 -43 -77%
JP Morgan Chase
20
JP Morgan Chase
New York
$19 -$3 -1 -8%
FDCDDQ
21
Federation des caisses Desjardins du Quebec
Quebec, Canada
$15 -$16 -5 -36%
AF
22
Allworth Financial
California
$11 – – –
TWC
23
TD Waterhouse Canada
Ontario, Canada
$7 – – –
AWM
24
Activest Wealth Management
Florida
$5 – – –
AWM
25
AllSquare Wealth Management
New York
$5 – – –
1
2

BNGO Hedge Fund Activity: Q3 2025 in Review

32 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q3 2025, worth a combined $417K — up 27% from $329K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new BNGO positions and 5 closed out — a net gain of 3 holders — while 5 added to existing stakes and 7 trimmed.

The largest buyer was UBS Group, adding an estimated $195K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $131K sold.

  • 32 institutional investors held Bionano Genomics (BNGO) as of Q3 2025, up from 29 in Q2 2025.
  • Funds reported $417K of Bionano Genomics stock for Q3 2025, up 27% quarter-over-quarter.
  • 8 funds opened new Bionano Genomics positions in Q3 2025 and 5 closed out, a net change of +3 holders.
  • The largest Bionano Genomics buyer in Q3 2025 was UBS Group, an estimated $195K added.
  • The largest Bionano Genomics seller in Q3 2025 was GSA Capital Partners, an estimated $131K sold.

Based on aggregated 13F filings for Q3 2025.